Literature DB >> 21180211

Pattern of breast cancer in a tertiary care center.

A K Jha1, P K Hamal, J Jha, P Banthia, K Thakali, B K Basnet.   

Abstract

INTRODUCTION: Breast Cancer is the second commonest cause of cancer death in women. Almost all women survive breast cancer if it is detected before it starts to spread. The aim of the study is to analyze the demographical profile, stage of presentation, histological type, and treatment modalities of breast cancer in a tertiary care setting.
METHODS: Total 1141 cases of breast cancer had been followed retrospectively from 1999 to 2006 A.D. in a tertiary care center and their patterns were analyzed.
RESULTS: The mean age of presentation of breast cancer was 47.30 +/- 11.57 years in female and 59.03 +/- 14.63 in male, 31 (2.1%) cases of breast cancer were male. There were 123 (10.78%) stage I, 281 (24.62%) stage II, 466 (40.84%) stage III, and 271 (23.75%) stage IV patients. Infiltrating ductal carcinoma was the commonest variety 610 (53.5%). Chemotherapy was the mainstay for treatment of breast cancer 341 (29.9%) followed by surgery 287 (25.2%).
CONCLUSIONS: Breast cancer trend is rising with more in late and advanced stages, mostly due to lack of awareness. Infiltrating ductal carcinoma is the commonest variety. Chemotherapy is the most commonly used modality of treatment. Male breast cancer present late and is not so uncommon.

Entities:  

Mesh:

Year:  2010        PMID: 21180211

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.406


  2 in total

1.  Preliminary Study on Serum Lactate Dehydrogenase (LDH)-Prognostic Biomarker in Carcinoma Breast.

Authors:  Aditi Agrawal; Mahendra Bhauraoji Gandhe; Dilip Gupta; M V R Reddy
Journal:  J Clin Diagn Res       Date:  2016-03-01

2.  Quality of Life of Nepalese Women Post Mastectomy

Authors:  Muna Maharjan; Niresh Thapa; Raj Devi Adhikari; Marcia A Petrini; Kapendra Shekhar Amatya
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.